共 50 条
- [1] Identity of single-nucleotide polymorphisms used in a clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy: comment on the article by Wessels et al [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (04): : 1204 - 1205
- [2] Identity of single-nucleotide polymorphisms used in a clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy: comment on the article by Wessels et al - Reply [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (04): : 1205 - 1205
- [3] Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (04): : 1087 - 1095
- [5] Single nucleotide polymorphisms (SNPs) in the folate/purine synthesis pathway predict methotrexate's effects in rheumatoid arthritis [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S438 - S438
- [6] Single nucleotide polymorphisms in genes coding for folate pathway enzymes are determinants for methotrexate efficacy in early rheumatoid arthritis [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S351 - S352
- [8] Methotrexate polyglutamate concentrations and association with disease control in rheumatoid arthritis: comment on the article by Stamp et al [J]. ARTHRITIS AND RHEUMATISM, 2010, 62 (08): : 2559 - 2560
- [10] Methotrexate polyglutamate concentrations and association with disease control in rheumatoid arthritis: comment on the article by Stamp et al Reply [J]. ARTHRITIS AND RHEUMATISM, 2010, 62 (08): : 2560 - +